tiprankstipranks
Greenwich LifeSciences (GLSI)
NASDAQ:GLSI
US Market
Holding GLSI?
Track your performance easily

Greenwich LifeSciences (GLSI) Ownership - Who Owns Greenwich LifeSciences?

366 Followers

Greenwich LifeSciences (GLSI) Ownership Overview

44.13%3.18%0.14%3.65%48.91%
44.13% Insiders
0.14% Other Institutional Investors
3.65% ETFs
48.91% Public Companies and
Individual Investors
The ownership structure of Greenwich LifeSciences (GLSI) stock is a mix of institutional, retail, and individual investors. Approximately 6.97% of the company’s stock is owned by Institutional Investors, 44.13% is owned by Insiders, and 48.91% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 25, 2024
Jaye Thompson
Vp Clinical Reg Affairs
xxxxxxxxxxxxx
$12910
Sep 30, 2024
Snehal Patel
Ceo And Cfo,director, >10% Owner
xxxxxxxxxxxxx
$21945
Sep 16, 2024
Jaye Thompson
Vp Clinical Reg Affairs
xxxxxxxxxxxxx
$11080
Aug 08, 2024
Snehal Patel
Ceo And Cfo,director, >10% Owner
xxxxxxxxxxxxx
$27620

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,536,102Insider42.12%77,173,262
264,148Insider2.01%3,682,223
258,151Institution1.96%3,598,625
224,770Institution1.71%3,133,294
215,692Institution1.64%3,006,746
67,053Institution0.51%934,719
53,878Institution0.41%751,059
30,268Institution0.23%421,936
16,455Institution0.13%229,383
8,122Institution0.06%113,221

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
224,770Institution1.71%3,133,294
67,053Institution0.51%934,719
53,878Institution0.41%751,059
30,268Institution0.23%421,936
16,455Institution0.13%229,383
8,122Institution0.06%113,221
4,233Institution0.03%59,008
3,140Institution0.02%43,772
2,800Institution0.02%39,032
2,755Institution0.02%38,405

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
151,149Institution1.15%2,107,017
153,459Institution1.17%2,064,024
71,311Institution0.54%959,133
51,081Institution0.39%712,069
27,208Institution0.21%365,948
14,129Institution0.11%196,958
5,630Institution0.04%75,724
3,332Institution0.03%45,149
575Institution<0.01%7,786
543Institution<0.01%7,303

FAQ

Who Owns Greenwich LifeSciences (GLSI)?
According to the latest TipRanks data, approximately 0.14% of the company's stock is held by institutional investors, 44.13% is held by insiders, and 48.91% is held by retail investors.
    What percentage of Greenwich LifeSciences (GLSI) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.14% of Greenwich LifeSciences (GLSI) stock is held by institutional investors.
      What percentage of Greenwich LifeSciences (GLSI) stock is held by retail investors?
      According to the latest TipRanks data, approximately 48.91% of Greenwich LifeSciences (GLSI) stock is held by retail investors.
        Who owns the most shares of Greenwich LifeSciences (GLSI)?
        Snehal Patel owns the most shares of Greenwich LifeSciences (GLSI).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis